Weight loss quality

Weight loss, MASH, and the ECM

Lisa Boyette, Late-Phase MASLD Program Lead, Eli Lilly

Abstract:TBD

GLP-1 agonists from bench to bed

Tina Vilsbøll, Senior medical officer, Novo Nordisk

Abstract: TBD

Effect of GLP-1 agonism on ECM modulation in MASH

Mads Almose Røpke, Scientific director, Novo Nordisk

Abstract: TBD

Effect of GLP-1 agonism on ECM modulation in CKD 

Alexander Lynge Reese-Petersen, , Principal scientist, Novo Nordisk

Abstract: TBD